Autoimmune Aspects of Type 2 Diabetes Mellitus - A Mini-Review
The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.
Abstract
Autoimmunity is a well-known pathogenic component in type 1 diabetes (T1DM). The assumption that the pathogenesis of type 2 diabetes (T2DM) also encompasses autoimmune aspects is recognized increasingly, based on the presence of circulating autoantibodies against β cells, self-reactive T cells, but also on the glucose-lowering efficacy of some immunomodulatory therapies in T2DM. The identification of these autoantibodies in elderly patients with slowly progressive manifestation of diabetes led to the introduction of a distinct clinical entity termed latent autoimmune diabetes of the adult (LADA), which combines features of both T1DM and T2DM. The autoantibody cluster differs in patients with LADA from patients with T1DM, but their presence indicates steady progression towards β-cell death and subsequent need for initiation of insulin treatment in a shorter period of time compared to autoantibody-negative T2DM patients. Autoimmune aspects in T2DM are not solely restricted to autoantibodies and thus LADA. They include the self-reactive T cells or defects in regulatory T cells (Tregs), which have been detected in autoantibody-negative T2DM patients as well. One contributor to the autoimmune activation in T2DM seems to be the chronic inflammatory state, characteristic of this disease. Upon inflammation-induced tissue destruction, cryptic ‘self' antigens can trigger an autoimmune response, which in turn accelerates β-cell death. Both innate and adaptive immune system components, specifically macrophages and self-reactive T cells, contribute to an increased secretion of inflammatory cytokines involved in inflammatory and autoimmune processes. However, the extent to which inflammation overlaps with autoimmunity is not known. Our review focuses on autoimmune involvement in T2DM, with an emphasis on LADA and the humoral immune response, on the involvement of chronic inflammation in autoimmunity, and specifically the role of B and T cells as links between inflammatory and autoimmune reactions. We will further stress the consequences of autoimmune activation for T2DM patients and present novel therapeutic approaches for T2DM management that rely on immune modulation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Interestingly, over recent years, it has become increasingly recognised that the aetiology of T2D encompasses autoimmune activity, similar to T1D.313”
From A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives (2021) · cites this paper as [313]
In the citing paper
“Strikingly, studies have demonstrated that islet-reactive T-cells can be found in phenotypic human T2D patients, and many studies have found that a subset of T2D patients test positive for islet beta-cell autoantibodies - these T-cells and antibodies are usually associated with T1D pathogenesis.313”
From A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives (2021) · cites this paper as [313]
Citations
Cites
Wild, S., Roglic, G., Green, A., Sicree, R., & King, H. (2004) · Diabetes Care · doi:10.2337/diacare.27.5.1047 · Cited by 15,297
Xu, H., Barnes, G. T., Yang, Q., Tan, G., Yang, D., Chou, C. J., Sole, J., Nichols, A., Ross, J. S., Tartaglia, L. A., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319451 · Cited by 6,760
Origin and physiological roles of inflammation
Medzhitov, R. (2008) · Nature · doi:10.1038/nature07201 · Cited by 6,618
The Danger Model: A Renewed Sense of Self
Matzinger, P. (2002) · Science · doi:10.1126/science.1071059 · Cited by 4,205
Type 2 diabetes as an inflammatory disease
Donath, M. Y., & Shoelson, S. E. (2011) · Nature Reviews Immunology · doi:10.1038/nri2925 · Cited by 3,737
Adipose tissue, adipokines, and inflammation
Fantuzzi, G. (2005) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2005.02.023 · Cited by 2,606
Adipokines: inflammation and the pleiotropic role of white adipose tissue
Trayhurn, P., & Wood, I. S. (2004) · British Journal of Nutrition · doi:10.1079/bjn20041213 · Cited by 2,210
Feuerer, M., Herrero, L., Cipolletta, D., Naaz, A., Wong, J., Nayer, A., Lee, J., Goldfine, A. B., Benoist, C., Shoelson, S., et al. (2009) · Nature Medicine · doi:10.1038/nm.2002 · Cited by 2,145
B cells regulate autoimmunity by provision of IL-10
Fillatreau, S., Sweenie, C. H., McGeachy, M. J., Gray, D., & Anderton, S. M. (2002) · Nature Immunology · doi:10.1038/ni833 · Cited by 1,647
Danger signals: SOS to the immune system
Gallucci, S., & Matzinger, P. (2001) · Current Opinion in Immunology · doi:10.1016/s0952-7915(00)00191-6 · Cited by 1,204
Cited by
Reed, J., Bain, S., & Kanamarlapudi, V. (2021) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s319895 · Cited by 441
Adult-onset autoimmune diabetes: current knowledge and implications for management
Buzzetti, R., Zampetti, S., & Maddaloni, E. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.99 · Cited by 271
“Furthermore, a new autoantibody against the extracytoplasmatic (EC) IA-2EC(26-577) region can identify a novel antigenic determinant within the N terminus of the IA-2 protein76.”
BackgroundProfile of the Immune and Inflammatory Response in Individuals With Prediabetes and Type 2 Diabetes
Grossmann, V., Schmitt, V. H., Zeller, T., Panova-Noeva, M., Schulz, A., Laubert-Reh, D., Juenger, C., Schnabel, R. B., Abt, T. G. J., Laskowski, R., et al. (2015) · Diabetes Care · doi:10.2337/dc14-3008 · Cited by 257
“to an islet cell autoimmunity in type 2 diabetes through activation of T cells, B cells, and macrophages, increased expression of b-cell antigens, and subsequent b-cell apoptosis (5).”
BackgroundInfluentialAn Overview of Herbal Products and Secondary Metabolites Used for Management of Type Two Diabetes
Ota, A., & Ulrih, N. P. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00436 · Cited by 216
“Recent studies have also shown the pathological involvement of the immune system in type 2 diabetes, that is, based on the presence of autoantibodies against β cells, selfreactive T cells and evidence of beneficial effect of some antiinflammatory and immunomodulatory therapy, being viewed as an autoinflammatory diseas…”
Backgroundde Melo, L. G. P., Nunes, S. O. V., Anderson, G., Vargas, H. O., Barbosa, D. S., Galecki, P., Carvalho, A. F., & Maes, M. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.04.027 · Cited by 189
Highly increased risk of type 2 diabetes in patients with binge eating disorder and bulimia nervosa
Raevuori, A., Suokas, J., Haukka, J., Gissler, M., Linna, M., Grainger, M., & Suvisaari, J. (2015) · International Journal of Eating Disorders · doi:10.1002/eat.22334 · Cited by 150
Current and future therapies for type 1 diabetes
von Scholten, B. J., Kreiner, F. F., Gough, S. C. L., & von Herrath, M. (2021) · Diabetologia · doi:10.1007/s00125-021-05398-3 · Cited by 173
The Telomere/Telomerase System in Chronic Inflammatory Diseases. Cause or Effect?
Kordinas, V., Ioannidis, A., & Chatzipanagiotou, S. (2016) · Genes · doi:10.3390/genes7090060 · Cited by 140
“There have been many reports recognizing a low grade chronic inflammation in diabetes as pathogenesis and a disease progressing mechanism [92,93].”
BackgroundKhawandanah, J. (2019) · Nutrition and Diabetes · doi:10.1038/s41387-019-0101-1 · Cited by 153
Chang, D., Gao, F., Slavney, A., Ma, L., Waldman, Y. Y., Sams, A. J., Billing-Ross, P., Madar, A., Spritz, R., & Keinan, A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0113684 · Cited by 123
“Furthermore, motivated by the unique characteristics of genes on X, we implemented the first gene-based test for associating X-linked genes and conducted an extensive XWAS of a number of AID and other diseases with a potential autoimmune component [70, 71].”
MethodType 2 Diabetes: How Much of an Autoimmune Disease?
de Candia, P., Prattichizzo, F., Garavelli, S., Rosa, V. D., Galgani, M., Rella, F. D., Spagnuolo, M. I., Colamatteo, A., Fusco, C., Micillo, T., et al. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00451 · Cited by 130
“However, some features of the inflammatory trajectory accompanying all the stages of T2D are likely ascribable to low-grade, subclinical, autoimmune phenomena (68, 69, 72, 115).”
BackgroundMaddaloni, E., Lessan, N., Al Tikriti, A., Buzzetti, R., Pozzilli, P., & Barakat, M. T. (2015) · PLOS ONE · doi:10.1371/journal.pone.0131837 · Cited by 93
MicroRNA Post-transcriptional Regulation of the NLRP3 Inflammasome in Immunopathologies
Tezcan, G., Martynova, E. V., Gilazieva, Z. E., McIntyre, A., Rizvanov, A. A., & Khaiboullina, S. F. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00451 · Cited by 85
ER stress and development of type 1 diabetes
Engin, F. (2016) · Journal of Investigative Medicine · doi:10.1097/jim.0000000000000229 · Cited by 83
Does Hsp60 Provide a Link between Mitochondrial Stress and Inflammation in Diabetes Mellitus?
Juwono, J., & Martinus, R. D. (2016) · Journal of Diabetes Research · doi:10.1155/2016/8017571 · Cited by 71
mTOR: A double-edged sword for diabetes
Tuo, Y., & Xiang, M. (2018) · Journal of Leukocyte Biology · doi:10.1002/jlb.3mr0317-095rr · Cited by 53
Huang, G., Yin, M., Xiang, Y., Li, X., Shen, W., Luo, S., Lin, J., Xie, Z., Zheng, P., & Zhou, Z. (2016) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2779 · Cited by 56
Type 1 Diabetes-related Autoantibodies in Different Forms of Diabetes
Sørgjerd, E. P. (2019) · Current Diabetes Reviews · doi:10.2174/1573399814666180730105351 · Cited by 56
Lindblom, P., Wilhelmsson, P., Fryland, L., Matussek, A., Haglund, M., Sjöwall, J., Vene, S., Nyman, D., Forsberg, P., & Lindgren, P. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100860 · Cited by 46
“We included 8 health-related factors from the questionnaires in the analysis that we considered might influence the immune response; previous TBE disease [22], vaccination against other flaviviruses (yellow fever or Japanese encephalitis) [38], $2 tick-bites during the previous 3 months [39], pet-ownership (dog or cat…”
MethodLiu, S., Nong, W., Ji, L., Zhuge, X., Wei, H., Luo, M., Zhou, L., Chen, S., Zhang, S., Lei, X., et al. (2023) · Experimental Gerontology · doi:10.1016/j.exger.2023.112132 · Cited by 52
Latent autoimmune diabetes in adults (LADA) in Asian and European populations
Kumar, A., & de Leiva, A. (2017) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2890 · Cited by 46
“Self reactive T cells (Tregs) have been detected in autoantibody‐negative DM2 patients.(71,72) T cells represent a strong link between inflammatory and autoimmune alterations.”
BackgroundOrgan-specific metabolic pathways distinguish prediabetes, type 2 diabetes, and normal tissues
Diamanti, K., Cavalli, M., Pereira, M. J., Pan, G., Castillejo-López, C., Kumar, C., Mundt, F., Komorowski, J., Deshmukh, A. S., Mann, M., et al. (2022) · Cell Reports Medicine · doi:10.1016/j.xcrm.2022.100763 · Cited by 45
“between the activation of the adaptive and the innate immune system and the progression of T2D have been demonstrated in earlier studies (de Candia et al., 2019; Itariu and Stulnig, 2014).”
Subsequent Type 2 Diabetes in Patients with Autoimmune Disease
Hemminki, K., Liu, X., Försti, A., Sundquist, J., Sundquist, K., & Ji, J. (2015) · Scientific Reports · doi:10.1038/srep13871 · Cited by 42
Buzzetti, R., Spoletini, M., Zampetti, S., Campagna, G., Marandola, L., Panimolle, F., Dotta, F., Tiberti, C., & for the NIRAD Study Group (NIRAD 8) (2015) · Diabetes Care · doi:10.2337/dc14-1638 · Cited by 41
“is involved in the pathogenesis of insulin resistance and type 2 diabetes (21), through the contribution of sev-”
BackgroundHuda, N., Hosen, M. I., Yasmin, T., Sarkar, P. K., Hasan, A., & Nabi, A. N. (2018) · PLoS ONE · doi:10.1371/journal.pone.0198507 · Cited by 34
Yehualashet, A. S. (2020) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s274844 · Cited by 33
Ellah, N. H. A., Ahmed, E. A., Abd-ellatief, R. B., Ali, M. F., Zahran, A. M., & Hetta, H. F. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s196842 · Cited by 33
“The uncontrolled inflammation results in pathogenesis of T2D through tissue destruction and activation of autoimmune response toward β-cells.(1,12,13) Accordingly, extensive attention has been paid to the role of the immune system and inflammation in progression and complications of DM.”
BackgroundLuan, C., Ye, Y., Singh, T., Barghouth, M., Eliasson, L., Artner, I., Zhang, E., & Renström, E. (2019) · Communications Biology · doi:10.1038/s42003-019-0351-4 · Cited by 31
Cintra, R. M. R., Moura, F. A., de Carvalho, L. S. F., Barreto, J., Tambascia, M. A., Pecoits‐Filho, R., & Sposito, A. C. (2019) · Revista da Associação Médica Brasileira · doi:10.1590/1806-9282.65.1.70 · Cited by 32
Qin, W., Liang, Y., Qin, B., Zhang, J., & Xia, N. (2016) · PLoS ONE · doi:10.1371/journal.pone.0156959 · Cited by 26
“Since LADA shares a number of characteristics with classic T1DM, it is also known as latent T1DM or slowly progressive T1DM[3].”
BackgroundCheng, L., Zhang, D., & Chen, B. Y. (2015) · Pakistan Journal of Medical Sciences · doi:10.12669/pjms.313.6964 · Cited by 24
Pang, Z., Kushiyama, A., Sun, J., Kikuchi, T., Yamazaki, H., Iwamoto, Y., Koriyama, H., Yoshida, S., Shimamura, M., Higuchi, M., et al. (2017) · The FASEB Journal · doi:10.1096/fj.201700110r · Cited by 27
Camille, N., & Dealtry, G. (2018) · South African Journal of Botany · doi:10.1016/j.sajb.2018.02.400 · Cited by 25
Diabetes mellitus: a risk factor for seizures in the elderly—a population-based study
Baviera, M., Roncaglioni, M. C., Tettamanti, M., Vannini, T., Fortino, I., Bortolotti, A., Merlino, L. G., & Beghi, E. (2017) · Acta Diabetologica · doi:10.1007/s00592-017-1011-0 · Cited by 25
“Although autoimmunity is a well-known pathogenic component of type 1 DM, the pathogenesis of type 2 DM also encompasses autoimmune aspects based on the presence of circulating autoantibodies against b cells, self-reactive T cells and also on the glucose lowering efficacy of some immunomodulatory therapies [20].”
Meier, H. C. S., Sandler, D. P., Simonsick, E. M., Weng, N., & Parks, C. G. (2020) · Experimental Gerontology · doi:10.1016/j.exger.2020.110906 · Cited by 19
T‐cell receptor repertoire variation may be associated with type 2 diabetes mellitus in humans
Frankl, J. A., Thearle, M. S., Desmarais, C., Bogardus, C., & Krakoff, J. A. (2015) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2720 · Cited by 19
Thyroid dysfunction among type 2 diabetic female Egyptian subjects
Elebrashy, I., Meligi, A. A. H. E., Rashed, L., Salam, R., Youseef, E., & Fathy, S. A. (2016) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s112302 · Cited by 18
“The significant positive correlation between both antithyroid antibodies and serum TSH in T2DM patients suggests that thyroid dysfunction in women with T2DM is due to an autoimmune-mediated pathogenetic mechanism, thus elevating the role of autoimmunity in the pathogenesis of T2DM.”
InfluentialLi, R., Huang, J., Yu, Y., & Yang, Y. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00260 · Cited by 17
“This was not surprising because innate as well as adaptive immune system might have a role in all types of diabetes, including type 2 diabetes (8, 20, 21).”
BackgroundInsulin Therapy and Autoimmune Disease with Relevance to Non Alchoholic Fatty Liver Disease
Martins, I. J. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.81297 · Cited by 17
Therapeutic Insights against Oxidative Stress Induced Diabetic Nephropathy: A Review
Agarwal, N., & Sadhukhan, P. (2015) · Journal of Autoimmune Disorders · doi:10.21767/2471-8153.100002 · Cited by 14
Lee, Y.-J., Fang, Y., Chen, M., Liou, H., Li, T.-H., & Tsai, M. (2025) · Journal of Autoimmunity · doi:10.1016/j.jaut.2025.103453 · Cited by 20
Type 1 diabetes: immune pathology and novel therapeutic approaches
Ling, E. M., Lemos, J. R. N., Hirani, K., & von Herrath, M. (2024) · Diabetology International · doi:10.1007/s13340-024-00748-z · Cited by 14
“The prevalence of T2D is increasing and if 10% of these patients are positive for islet autoantibodies then testing for them during the diagnostic assessment will be of benefit to many patients [105].”
Treatment of Latent Autoimmune Diabetes in Adults: What is Best?
Hals, I. K. (2019) · Current Diabetes Reviews · doi:10.2174/1573399814666180716144429 · Cited by 14
Sung, F., Chiu, H., Hung, C.-J., Muo, C., & Fan, K. (2020) · Indian Journal of Dermatology Venereology and Leprology · doi:10.4103/ijdvl.ijdvl_428_18 · Cited by 12
Chang, D. C., Piaggi, P., Hanson, R. L., Knowler, W. C., Bogardus, C., & Krakoff, J. A. (2017) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2922 · Cited by 13
“In addition, IL‐6 autoantibodies have been detected in sera from 2.5% of Danish participants withT2DM.14 There is evidence of a role for the innate and adaptive immune systems in the development of T2DM specifically in Southwest American Indians (SAIs), a group in which T2DM and obesity are highly prevalent, but with…”
InfluentialPutlyaeva, L. V., Демин, Д. Э., Korneev, K. V., Kasyanov, A. S., Tatosyan, K. A., Kulakovskiy, I. V., Kuprash, D. V., & Schwartz, A. M. (2018) · Biochemistry (Moscow) · doi:10.1134/s0006297918120118 · Cited by 12
Jeong, Y., Park, H., Nam, H.-K., & Lee, K. (2021) · Pharmaceuticals · doi:10.3390/ph14040299 · Cited by 11
Brooks‐Worrell, B., Tjaden, A. H., Edelstein, S. L., PALOMINO, B. M., Utzschneider, K. M., Arslanian, S. A., Mather, K. J., Buchanan, T. A., Nadeau, K. J., Atkinson, K. M., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.640251 · Cited by 12
“In fact, Th17 cells, effectors of autoimmune diseases, have been shown to be present in islet inflammation in both T1D and T2D, to be increased in the peripheral blood of T1D and T2D patients, and to be involved in pancreatic β-cell destruction in T1D (3, 4, 12, 15, 25, 26).”
BackgroundMoosaie, F., Meftah, N., Deravi, N., Abouhamzeh, K., Firouzabadi, F. D., Khaloo, P., Mansournia, M. A., Abhari, S. M. F., Nakhjavani, M., & Esteghamati, A. (2020) · Primary care diabetes · doi:10.1016/j.pcd.2020.07.008 · Cited by 13
GPR92 activation in islet macrophages controls β cell function in a diet-induced obesity model
de Souza, C. O., Paschoal, V. A., Sun, X., Vishvanath, L., Zhang, Q., Shao, M., Onodera, T., Chen, S., Joffin, N., Bueno, L. M. A., et al. (2022) · Journal of Clinical Investigation · doi:10.1172/jci160097 · Cited by 12
“Since a marked expansion of immune cells and increased production of proinflammatory cytokines and chemokines leading to the abrogation of β cell functions are common features of diet-induced obesity and T2D (7, 8, 11), we next evaluated the effects of GPR92 deficiency on the inflammatory features of IMs.”
BackgroundInfluentialSalauddin, A., Chakma, K., Hasan, M. M., Akter, F., Chowdhury, N. A., Chowdhury, S. R., & Mannan, A. (2022) · Molecular Biology Reports · doi:10.1007/s11033-022-08081-x · Cited by 10
“1 3 disorder, experts now propose that T2DM should also be categorized as an autoimmune disorder rather than a solely metabolic disorder [3].”
BackgroundD’Amico, F., Skarmoutsou, E., Lo, L. J., Granata, M., Trovato, C., Rossi, G. A., Bellocchi, C., Marchini, M., Scorza, R., Mazzarino, M. C., et al. (2016) · Immunology Letters · doi:10.1016/j.imlet.2016.11.011 · Cited by 11
Adipokines as potential biomarkers for type 2 diabetes mellitus in cats
Sierawska, O., & Niedźwiedzka‐Rystwej, P. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.950049 · Cited by 13
“T-lymphocytes, together with macrophages, by releasing pro-inflammatory cytokines, contribute to increased pancreatic islet inflammation (13).”
BackgroundInfluentialCheng, L., Zhang, D., & Chen, B. (2016) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2016.3457 · Cited by 9
Kostov, K. G., & Blazhev, A. B. (2022) · Pathophysiology · doi:10.3390/pathophysiology29030034 · Cited by 8
“A hallmark of autoimmune involvement in T2D is the presence of circulating autoantibodies [28].”
BackgroundGonzalez, C. E., Vaidya, R., Clayton, S. W., & Tang, S. Y. (2025) · Disease Models & Mechanisms · doi:10.1242/dmm.052384 · Cited by 9
Mendivil, C. O., Toloza, F. J. K., Ricardo-Silgado, M. L., Alvarez, M. C. M., Mantilla-Rivas, J. O., Pinzón-Cortés, J. A., & Lemus, H. N. (2017) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s137216 · Cited by 8
“Given that IR and beta-cell autoimmunity share some common biological underpinnings (abnormal activation of the immune system and the inflammatory response), the exploration of autoimmunity against components of pancreatic islets among nondiabetic persons with different degrees of IR may reveal interesting phenomena r…”
BackgroundPrevalence of hypothyroidism in type 2 diabetic female Kurdish subjects
Muhammed, S., & Albustani, D. (2018) · Medical Journal of Babylon · doi:10.4103/mjbl.mjbl_99_18 · Cited by 9
“Researchers recently found that anti-CD20, which targets and eliminates mature B cells, IL1-receptor antagonists (Anakinra), and a T-cell costimulation blocker (abatacept), may be beneficial in improving glucose control in T2DM.[20] Correlation between thyroid dysfunction and the different parameters of metabolic synd…”
BackgroundResultInfluentialPouresmaeil, V., Mashayekhi, S., & Yazdi, M. S. (2022) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-021-00956-3 · Cited by 10
“Hyperglycemia contributes to an increased expression of several antigens such as GAD, thus increasing the vulnerability of cells to autoantibodies such as anti-GAD, which are the autoantibodies most frequently detected in T2D [42].”
BackgroundCoexistence of acquired perforating dermatosis and bullous pemphigoid: three cases
Nomura, H., Mukai, M., Niimi, Y., Egami, S., Yokoyama, T., Sugiura, M., Inazumi, T., Ishii, N., & Hashimoto, T. (2017) · European Journal of Dermatology · doi:10.1684/ejd.2016.2944 · Cited by 7
Shen, J., Pan, J., Yu, G., Cai, H., Xu, H., Yan, H., & Feng, Y. (2024) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.70045 · Cited by 5
Class I MHC Polymorphisms Associated with Type 2 Diabetes in the Mexican Population
Mendoza-Ramírez, P., López-Olaiz, M. A., Morales-Fernández, A. L., Flores-Echiveste, M. I., Casillas-Navarro, A. D. J., Pérez-Rodríguez, M. A., Orozco-Luna, F. D. J., Cortés-Romero, C., Zúñiga, L. Y., Parada, M. G. S., et al. (2022) · Genes · doi:10.3390/genes13050772 · Cited by 6
“CD8(+) T cells may be cytotoxic upon binding to MHC-I molecules on the surface of pancreatic β-cells [36].”
BackgroundFrom obesity through immunity to type 2 diabetes mellitus
Szablewski, L. (2016) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-016-0531-4 · Cited by 5
Rajab, H. A., Hassan, A. B., Hassan, I. I., Abdulah, D. M., & Saadi, F. S. (2020) · PLoS ONE · doi:10.1371/journal.pone.0237109 · Cited by 5
Fakhroo, A. D., Nasarallah, G. K., Khan, T., Cyprian, F. S., Ali, F. A., Ata, M., Taleb, S., Hssain, A. A., Eid, A. H., Abu-Raddad, L. J., et al. (2022) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2022.076 · Cited by 5
Lekka, K., Marangos, M. N., Roupas, N. D., Καρακάντζα, Μ., Gogos, C., & Velissaris, D. (2020) · Journal of Clinical Medicine Research · doi:10.14740/jocmr4068 · Cited by 5
“However, the extent to which inflammation overlaps with autoimmunity is not known [14].”
BackgroundHeald, A. H., Qin, R., Williams, R., Warner-Levy, J. J., Narayanan, R. P., Fernandez, I., Peng, Y., Gibson, M., McCay, K. D., Anderson, S. G., et al. (2023) · Diabetes Therapy · doi:10.1007/s13300-023-01463-9 · Cited by 6
“Previous research has shown that inflammation brought on by underlying autoimmune diseases may be responsible for both the development of asthma and the later emergence of T2D [36].”
BackgroundTiberti, C., D’Onofrio, L., Panimolle, F., Zampetti, S., Maddaloni, E., & Buzzetti, R. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.921886 · Cited by 5
“In particular, the strict association between the immunoreactivity limited to the extracellular portion of the IA-2 protein and an obese phenotype might support a role for low-grade inflammation in developing an autoimmune process directed against the b-cell, which is, however, different from what is observed in lean…”
ResultScreening type 2 Diabetes mellitus among Indians using inflammatory biomarkers
Arif, M., Nigoskar, S., Verma, M., & Amir, A. H. (2024) · Bioinformation · doi:10.6026/973206300200515 · Cited by 5
Farré, X., Spataro, N., Haziza, F., Rambla, J., & Navarro, A. (2019) · Bioinformatics · doi:10.1093/bioinformatics/btz622 · Cited by 3
Yinhui, H., Haiyan, X., Qi, F. U., & Tao, Y. (2019) · Europe PMC (PubMed Central) · doi:10.12122/j.issn.1673-4254.2019.09.01 · Cited by 5
“In T2DM, the deterioration of islet function results from a variety of factors, such as glycolipid toxicity, islet autoimmunity, disease course, and metabolic syndrome[4-6].”
BackgroundHeald, A. H., Chang, K., Jia, T., Sun, H., Zheng, Q., Wang, X., Xia, J., Stedman, M., Fachim, H., Gibson, M., et al. (2021) · International Journal of Clinical Practice · doi:10.1111/ijcp.14695 · Cited by 3
Detection of autoimmune antibodies in severe but not in moderate or asymptomatic COVID-19 patientsPreprint
Fakhroo, A. D., Nasrallah, G. K., Khan, T., Cyprian, F. S., Ali, F. A., Ata, M., Taleb, S., Hssain, A. A., Eid, A. H., Abu-Raddad, L. J., et al. (2021) · medRxiv · doi:10.1101/2021.03.02.21252438 · Cited by 3
“be an autoimmune condition given the presence of circulating autoantibodies against β cells [17];”
BackgroundJaryal, A., & Vikrant, S. (2022) · Therapeutic Apheresis and Dialysis · doi:10.1111/1744-9987.13861 · Cited by 2
Autoimmune diseases and metabolic disorders: Molecular connections and potential therapeutic targets
Uddin, M. J., Tran, D. K., Hannan, M. A., Hasan-Al-Faruque, Rahman, M. A., Moni, A., Lam, N. T., Ngọc, V. T. N., & Chu, D. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-85415-3.00018-0 · Cited by 2
Ancestry-specific high-risk gene variant profiling unmasks diabetes-associated genes
Zhang, J., Chen, W., Chen, G., Flannick, J. A., Fikse, E., Smerin, G., Degner, K. N., Yang, Y., Xu, C., Li, Y., et al. (2022) · Human Molecular Genetics · doi:10.1093/hmg/ddac255 · Cited by 2
Chaudhary, D., Jiang, Y., Khan, F., Mathur, P., Pinkston, C. M., & Abell, T. L. (2024) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000002062 · Cited by 2
He, M., Niu, J., Cheng, H., & Guo, C. (2024) · Frontiers in Genetics · doi:10.3389/fgene.2024.1373807 · Cited by 3
“Many studies have shown that T2DM is also considered an autoimmune disease (Itariu and Stulnig, 2014; Wang et al., 2023; Zhou et al., 2018).”
BackgroundKudabayeva, K. I., Tleumagambetova, B., Bazargaliyev, Y., Космуратова, Р. Н., & Zhylkybekova, A. (2024) · Journal of Diabetes Research · doi:10.1155/2024/4960075 · Cited by 5
Zampetti, S., & Buzzetti, R. (2018) · Endocrinology · doi:10.1007/978-3-319-45015-5_9 · Cited by 2
Khoshroo, M. (2016) · International Journal of Pure & Applied Bioscience · doi:10.18782/2320-7051.2387 · Cited by 3
L’internista ospedaliero nella gestione del paziente diabetico complesso
Magnani, G. E. L., Beltramello, G., Brancato, D., Fontanella, A., & Nardi, R. (2018) · Italian Journal of Medicine · doi:10.4081/itjm.q.2018.2 · Cited by 2
Nagral, A. S., Rudra, O. S., Adhyaru, K., Gharat, A., & Bhandare, S. (2021) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2021.09.020 · Cited by 2
“Even in DM, where there is evidence of TC to lower sugars, one may need to be cautious while using the drug, especially in a subset of diabetics with an autoimmune basis.(9) We agree that the denominator of people consuming Giloy will be very large.”
BackgroundPrevalence of IA-2 antibody in patients suffering from diabetes and their first-degree relatives
Bolandi, V., Azghadi, S. K., Shahami, M., & Fereidouni, M. (2020) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-020-00882-9 · Cited by 1
Zhong, H., Sun, G.-J., Du, F.-M., Wang, W., Duan, B., & Qiao, H. (2025) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-025-01895-2 · Cited by 1
“Recent studies have revealed that immune abnormalities are also widespread in T2DM patients [23–25].”
Xiang, M., Liu, S., Xiao, D., & Tao, Y. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-026-02810-5 · Cited by 1
“222,223 Notably, nonobese T2DM exhibits distinct immunological characteristics, including signi fi cant elevation of IL-6 + Th17 cells and their signature cytokines (IL-6/IL-17), implicating their pathogenic role.”
TYPE 2 DIABETES MELLITUS – AN AUTOIMMUNE DISEASE?
Asfandiyarova, N. S. (2020) · Russian Journal of Immunology · doi:10.46235/1028-7221-001-tdm · Cited by 1
“Сторонники участия аутоиммунитета в развитии заболевания, приводя аргументы, свидетельствующие о выявлении аутоиммунных реакций у пациентов с этой формой диабета, осторожно высказываются об их значимости в генезе заболевания, рассматривая аутоиммунный феномен либо как первопричину СД, либо как следствие β-клеточной де…”
Is Type 2 Diabetes an Autoimmune Disorder of Gradual Onset?
Kotsa, K. (2014) · Journal of Diabetes Metabolic Disorders & Control · doi:10.15406/jdmdc.2014.01.00018 · Cited by 1
“Studies are underway to determine whether early treatment with insulin or use of immunomodulator therapy can prevent disease progression [17,18].”
BackgroundEickenscheidt, L., Pönnighaus, J. M., & Kowalzick, L. (2019) · Aktuelle Dermatologie · doi:10.1055/a-0881-6683
Dysfunction and Death of Pancreatic Beta Cells in Type 2 Diabetes
Ortega‐Camarillo, C. (2019) · Springer eBooks · doi:10.1007/978-3-030-11815-0_12 · Cited by 2
Xianzhao, F., Ming, H., Xian, Q. H., Li, C., Wen-hua, H., Qiuxia, C., & Mian, L. (2020) · Science Journal of Public Health · doi:10.11648/j.sjph.20200806.12
Geltser, D. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s308746
Li, Y., Kao, T., Kuo, C.-Y., Chang, P.-K., Chen, W., & Wu, L. (2021) · Research Square · doi:10.21203/rs.3.rs-141932/v1
“In the tissues where they are generated, cytokines such as IL-6, IL- 1β, and TNF-α hold the capability of promoting insulin resistance and then in uence other locations through circulation including cardiac and skeletal muscle as well as endothelium of vascular walls(45, 46).”
BackgroundCell-mediated immunity in visceral obesity
Asfandiyarova, N. S., Zhuravleva, N., Skopin, A., Borozdin, A., Trunina, T. I., & Girivenko, A. I. (2016) · Immunopathology Allergology Infectology · doi:10.14427/jipai.2016.4.12
Diabetes Mellitus: sua influência na resposta inflamatória e na evolução clínica da sepse
Silveira, L. M. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.22.2019.tde-20032020-151715
Li, Y., Kao, T., Kuo, C.-Y., Chang, P.-K., Chen, W., & Wu, L.-W. (2021) · Research Square · doi:10.21203/rs.3.rs-141932/v2
Zampetti, S., & Buzzetti, R. (2018) · Endocrinology · doi:10.1007/978-3-319-27317-4_9-1
Dysfunction and Death of Pancreatic Beta-Cells in Type 2 Diabetes
Ortega‐Camarillo, C. (2023) · Springer eBooks · doi:10.1007/978-3-031-25519-9_13
Managing Type 2 Diabetes Mellitus by Coupling Immunity Modulatory and Antidiabetic properties
Kushwaha, S. P., Hasan, S. S., Singh, K., Kumar, A., & Muhammad, A. (2025) · Research Journal of Pharmacy and Technology · doi:10.52711/0974-360x.2025.00005
Clinical Insights Into Anti‐Sulfatide Antibodies in Peripheral Neuropathies: A Retrospective Study
Duan, R., Si, W.-Y., Liu, Y., Liu, Y., & Duan, R. (2025) · Acta Neurologica Scandinavica · doi:10.1155/ane/8906829
“So far, anti-sulfatide antibodies were not found to correlate with T2DM; however, sulfatide might be involved in T2DM [23], and autoimmune reactions may also contribute to the pathogenesis of T2DM [24].”
Metadata
- Authors
- Itariu, B. K., & Stulnig, T. M.
- Affiliations
- Medical University of Vienna (AT)
- Venue
- Gerontology
- Publisher
- S. Karger AG
- Published
- 2014
- Volume
- 60
- Issue
- 3
- Pages
- 189-196
- ISSN
- 0304-324X (ISSN-L)
- 1423-0003
- OpenAlex
- W2043428857
- Cited by
- 107
- References
- 69
- Citations by year
- 2026: 4 · 2025: 5 · 2024: 6 · 2023: 3 · 2022: 12 · 2021: 11 · 2020: 9 · 2019: 15 · 2018: 9 · 2017: 10 · 2016: 10 · 2015: 8 · 2014: 5
- FWCI
- 1.46
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- Gerontology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Research Foundation
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Keywords
- type 2 diabetes, autoimmunity, beta-cell autoantibodies, autoreactive T cells, regulatory T cells, chronic inflammation, beta-cell death, immunomodulatory therapy, B cells, T cells, macrophages, inflammatory cytokines, elderly patients
- MeSH terms
- Adult, Aged, Animals, Autoimmune Diseases, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Female, Glutamate Decarboxylase, Humans, Lymphocytes, Male, Middle Aged, Autoimmunity, Models, Immunological, Insulin-Secreting Cells, Immunomodulation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.